HUE031877T2 - Eljárás vorikonazol és analógjai elõállítására - Google Patents

Eljárás vorikonazol és analógjai elõállítására Download PDF

Info

Publication number
HUE031877T2
HUE031877T2 HUE13795583A HUE13795583A HUE031877T2 HU E031877 T2 HUE031877 T2 HU E031877T2 HU E13795583 A HUE13795583 A HU E13795583A HU E13795583 A HUE13795583 A HU E13795583A HU E031877 T2 HUE031877 T2 HU E031877T2
Authority
HU
Hungary
Prior art keywords
alkyl
bis
chloro
minutes
added
Prior art date
Application number
HUE13795583A
Other languages
English (en)
Inventor
Adam James Musgrave Burrell
Padraig Mary O'neill
Alan John Pettman
Original Assignee
Pfizer Ireland Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ireland Pharmaceuticals filed Critical Pfizer Ireland Pharmaceuticals
Publication of HUE031877T2 publication Critical patent/HUE031877T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Claims (2)

  1. é ΛΛ :.4¾ W g! /¾. S* « £, > > >· > -¾ £. à ο. νΐ ,¾ I. Ë ·;: ·;·· I >ι I I ι 1: s· « s f s ® % i: * :ί> '< '·:;·: '·:' £' . " ν>: t t s: 1 a ti' 1 &amp;: s % :< " â % ftf » S £ 0 V :** 4* ST- ’"v *·< 1 I t i £ 1 g; < % :>
    t-: 4 g # S. * ?? t| χ .§· f f >-/ - « &amp;: «=. '· % X fí' f?· .3- w fi. :¾ ?r g ä 'Z ZZ. ή'·· ·.·«' Λ Æ1 XX s? i;<ï Wi ÍS £ 'Si- 4 x: f: «£ g -f
    cr t^r‘ ££· >- ci ^ ** y. j η
    -Í· 1·. ,; '* /.> <*i O; ^ f#> λ: ^ ;î ., ·<· % - 2. .£ i K! f ':. %· I I % « :;:· S ? e Ί ;;: f I i: I f: 11 I I § 1 :?.. £ 3 Si' ?! 2; 2 XV 2. f 1' S 3 « % I f I * r fr: S :â. Sx: I a % S t ^ f: :ïï m t $ ^ ;f 1 ï ÿ 2 ! 1 S I I f Í ί ï I ! i I S •V. S 4 4 4 z- Sx N V.ï. -;.'· î»: ÍV- /¾ .< '..λ . -y-y· yf B* fvi: :r:- ·;,' £, X « {,. £. w ;;; a 1 £ ä i;: i |; R H- § -s a a ··;·. * ·χ - w ?:' “ £, .X .c: &amp; < g: |. -s I I -r ^ I ä Æ f ” f 1, I -f Sr ,y S S: ‘ 1 ï;.· X* 4e/· <1 ·Α· a 5, gCßyBmU SáCCgi sb|íái, sh»! à ksíaiiaá-or a (! «sF« PPh·. ·; «miand ·*.?:«;·>á; vagy Cu F( PFí:·,}; aíaruF :;:í;í S va;
  2. 7, A a aiikö igcavpmam· bánndyska ::-agí!mj Cjsráy. «M s bpadgip «a (a;· I Cí-SaHk-fk-(iiiiaak íoa;'ni'Kí)t'F«in fbíroaesni : Síiisna; C5-bu-a (írsOgörrksiii)íébFIiÇsaig. :s. .Aa eiôaà :genyyont«k kánueiy ike SMiigií diám. ahol &amp; fS<|yká|Ssa®r iböiJsSiÄ 7; At sî«ko lg«Çyps>uiok b«jrgi§|yjbé saefgg; «bégig, aggka mkeió ivvmm\n;e kb. ·Ά;:Γ SO. Λ a alúaó igánvpomi: hanndyike sasribb Ciam. ahoi a $ç.rmck vorikoaayoi vagy g ®nP«kbi íovabbsiaksikik agy vagy íCbb ÍSpééb«B, Çs így vsgkgBSkgU állnunk «IÇ. 1 ;. vegya iák ameiy a 4 vkjga-5 ·· fém à·# : vs r> í sgi f jm lib iá; $-Huííí '-FvíBigann;|pm:; vagy 74: iíMaé-fi sJO!>4-:Vífblpl gin iá in.
HUE13795583A 2012-10-15 2013-10-08 Eljárás vorikonazol és analógjai elõállítására HUE031877T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261713761P 2012-10-15 2012-10-15

Publications (1)

Publication Number Publication Date
HUE031877T2 true HUE031877T2 (hu) 2017-08-28

Family

ID=49641810

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE13795583A HUE031877T2 (hu) 2012-10-15 2013-10-08 Eljárás vorikonazol és analógjai elõállítására

Country Status (23)

Country Link
US (2) US9388167B2 (hu)
EP (1) EP2906555B1 (hu)
JP (1) JP6180533B2 (hu)
KR (1) KR101706488B1 (hu)
CN (1) CN104884450B (hu)
AU (1) AU2013333534B2 (hu)
BR (1) BR112015007821B1 (hu)
CA (1) CA2888127A1 (hu)
CY (1) CY1118451T1 (hu)
DK (1) DK2906555T3 (hu)
ES (1) ES2615743T3 (hu)
HU (1) HUE031877T2 (hu)
IL (1) IL238209A (hu)
IN (1) IN2015DN02877A (hu)
MX (1) MX358245B (hu)
NZ (1) NZ706764A (hu)
PL (1) PL2906555T3 (hu)
PT (1) PT2906555T (hu)
RU (1) RU2619928C2 (hu)
SG (1) SG11201502237RA (hu)
SI (1) SI2906555T1 (hu)
WO (1) WO2014060900A1 (hu)
ZA (1) ZA201501904B (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2015DN02877A (hu) * 2012-10-15 2015-09-11 Pfizer Ireland Pharmaceuticals
CN106432198B (zh) * 2016-09-08 2022-10-21 浙江华海药业股份有限公司 一种制备伏立康唑拆分中间体的方法
CN112898273B (zh) * 2021-03-30 2022-05-31 海南锦瑞制药有限公司 伏立康唑的合成方法及应用
CN113185465B (zh) * 2021-05-26 2022-09-27 无锡捷化医药科技有限公司 一种4-乙基-5-氨基嘧啶的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8819308D0 (en) * 1988-08-13 1988-09-14 Pfizer Ltd Triazole antifungal agents
GB9002375D0 (en) 1990-02-02 1990-04-04 Pfizer Ltd Triazole antifungal agents
GB9516121D0 (en) * 1995-08-05 1995-10-04 Pfizer Ltd Organometallic addition to ketones
CA2590687C (en) * 2004-12-14 2013-09-10 Dr. Reddy's Laboratories Ltd. Process for preparing voriconazole
AU2005323797B2 (en) 2005-01-10 2009-07-09 Pfizer Inc. Pyrrolopyrazoles, potent kinase inhibitors
KR100889937B1 (ko) * 2007-08-06 2009-03-20 한미약품 주식회사 보리코나졸의 제조방법
WO2011045807A2 (en) * 2009-10-14 2011-04-21 Neuland Laboratories Ltd. A novel process to manufacture (2r,3s)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1h-1,2,4-triazol-1-yl)butan-2-ol
CN103814020B (zh) * 2011-06-17 2017-07-14 安吉奥斯医药品有限公司 治疗活性组合物和它们的使用方法
CN102827073A (zh) * 2011-06-17 2012-12-19 安吉奥斯医药品有限公司 治疗活性组合物和它们的使用方法
WO2014048065A1 (en) * 2012-09-28 2014-04-03 Merck Sharp & Dohme Corp. Triazolyl derivatives as syk inhibitors
IN2015DN02877A (hu) * 2012-10-15 2015-09-11 Pfizer Ireland Pharmaceuticals
JO3383B1 (ar) 2013-03-14 2019-03-13 Lilly Co Eli مثبطات cdc7

Also Published As

Publication number Publication date
RU2015113741A (ru) 2016-12-10
MX2015004450A (es) 2015-06-24
CN104884450B (zh) 2017-03-29
US9388167B2 (en) 2016-07-12
US9499520B2 (en) 2016-11-22
JP6180533B2 (ja) 2017-08-16
SG11201502237RA (en) 2015-05-28
JP2015536305A (ja) 2015-12-21
US20160229842A1 (en) 2016-08-11
SI2906555T1 (sl) 2017-02-28
ES2615743T3 (es) 2017-06-08
NZ706764A (en) 2017-11-24
IN2015DN02877A (hu) 2015-09-11
AU2013333534B2 (en) 2016-04-14
AU2013333534A1 (en) 2015-04-09
US20150239867A1 (en) 2015-08-27
CN104884450A (zh) 2015-09-02
EP2906555A1 (en) 2015-08-19
PL2906555T3 (pl) 2017-07-31
BR112015007821A2 (pt) 2017-07-04
CA2888127A1 (en) 2014-04-24
EP2906555B1 (en) 2016-12-14
KR20150055009A (ko) 2015-05-20
PT2906555T (pt) 2017-02-15
ZA201501904B (en) 2017-01-25
RU2619928C2 (ru) 2017-05-22
HK1213891A1 (zh) 2016-07-15
MX358245B (es) 2018-08-10
KR101706488B1 (ko) 2017-02-13
WO2014060900A1 (en) 2014-04-24
DK2906555T3 (en) 2017-02-06
CY1118451T1 (el) 2017-07-12
IL238209A0 (en) 2015-06-30
BR112015007821B1 (pt) 2022-02-15
IL238209A (en) 2017-07-31

Similar Documents

Publication Publication Date Title
HUE031248T2 (hu) Új biciklusos piridinonok
DK2906555T3 (en) Process for the preparation of voriconazole and analogs thereof
EP2792664B1 (en) Optical resolution method for bicyclic compound using asymmetric catalyst
Fukuda et al. Synthetic studies on macrolactin A by using a (diene) Fe (CO) 3 complex
Siyutkin et al. N-Pyrrolidine-2-ylmethyl)-2-hydroxy-3-aminopinanes as novel organocatalysts for asymmetric conjugate additions of ketones to α-nitroalkenes
Gangar et al. Anti selective glycolate aldol reactions of (S)-4-isopropyl-1-[(R)-1-phenylethyl] imidazolidin-2-one: Application towards the asymmetric synthesis of 8-4′-oxyneolignans
Asenjo et al. Asymmetric 1, 3-dipolar cycloaddition reactions between enals and nitrones catalysed by half-sandwich rhodium or iridium diphosphane complexes
HK1213891B (en) Process for the preparation of voriconazole and analogues thereof
TWI601713B (zh) 製備選擇性經取代之苯基及吡啶基吡咯啶類的方法
WO2013146987A1 (ja) ロジウム触媒及びアミン化合物の製造法
Tanpure Development of Carbenoid Eliminative Cross-coupling for the Stereocontrolled Synthesis of Trisubstituted Alkenyl Moieties Within Styrenes and 1, 3-Dienes
Bunya et al. Synthesis of Chiral (Suifinyl) furyloxazoline Ligands and its Application to Enantioselective Palladium-Catalyzed Allylic Alkylation
D'hooghe et al. Synthesis of 2-(3-hydroxy-2-methyl-1-alkenyl)-1-pyrrolines and 2-(3-hydroxybutyl)-1-pyrroline using α-lithiated 2-methyl-1-pyrroline
CN107614496A (zh) 制备氨基四氢吡喃化合物的方法
WO2010098193A1 (ja) β-アミノカルボニル化合物の製法及びリチウムビナフトラート錯体
US20070265255A1 (en) Synthesis, structure and use of bisoxazolidines for asymmetric catalysis and synthesis
Rao Development Of Optically Active Cyclopentadienyl Ruthenium Complexes and Their Application in Asymmetric Catalysis
Zorzitto Enantioselective Rh (I)-Catalyzed Conjugate Alkynylation of 5-Benzylidene Meldrum’s Acid with TMS-acetylene
Liberatore The Application of Ruthenium (II) and Iridium (I) Complexes to the Synthesis of Complex Organic Products
Liffey Asymmetric synthesis with sulfur (IV) and sulfur (VI)
HK1199017B (en) Optical resolution method for bicyclic compound using asymmetric catalyst
JP2012111721A (ja) 光学活性含フッ素オキセテンの製造方法